$170.63
1.59% yesterday
NYSE, Apr 03, 10:10 pm CET
ISIN
US74834L1008
Symbol
DGX

Quest Diagnostics Target price 2025 - Analyst rating & recommendation

Quest Diagnostics Classifications & Recommendation:

Buy
45%
Hold
55%

Quest Diagnostics Price Target

Target Price $180.69
Price $170.63
Potential
Number of Estimates 16
16 Analysts have issued a price target Quest Diagnostics 2026 . The average Quest Diagnostics target price is $180.69. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 22 analysts: 10 Analysts recommend Quest Diagnostics to buy, 12 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Quest Diagnostics stock has an average upside potential 2026 of . Most analysts recommend the Quest Diagnostics stock at Hold.

Sales and Margin forecast 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Billion $ 9.87 10.78
6.70% 9.23%
EBITDA Margin 19.33% 19.97%
0.10% 3.32%
Net Margin 8.61% 8.79%
4.54% 2.06%

16 Analysts have issued a sales forecast Quest Diagnostics 2025 . The average Quest Diagnostics sales estimate is

$10.8b
Unlock
. This is
9.23% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$10.8b 9.74%
Unlock
, the lowest is
$10.7b 8.40%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $9.9b 6.70%
2025
$10.8b 9.23%
Unlock
2026
$11.2b 4.05%
Unlock
2027
$11.7b 3.98%
Unlock
2028
$12.1b 3.93%
Unlock

14 Analysts have issued an Quest Diagnostics EBITDA forecast 2025. The average Quest Diagnostics EBITDA estimate is

$2.2b
Unlock
. This is
12.95% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$2.3b 20.25%
Unlock
, the lowest is
$2.0b 3.93%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $1.9b 6.59%
2025
$2.2b 12.83%
Unlock
2026
$2.3b 5.98%
Unlock
2027
$2.4b 6.13%
Unlock
2028
$2.6b 5.41%
Unlock

EBITDA Margin

2024 19.33% 0.10%
2025
19.97% 3.32%
Unlock
2026
20.34% 1.85%
Unlock
2027
20.76% 2.06%
Unlock
2028
21.05% 1.40%
Unlock

9 Quest Diagnostics Analysts have issued a net profit forecast 2025. The average Quest Diagnostics net profit estimate is

$948m
Unlock
. This is
10.89% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$1.1b 25.71%
Unlock
, the lowest is
$900m 5.27%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $850m 1.86%
2025
$948m 11.47%
Unlock
2026
$1.0b 10.20%
Unlock
2027
$1.1b 8.97%
Unlock
2028
$1.3b 10.61%
Unlock

Net Margin

2024 8.61% 4.54%
2025
8.79% 2.06%
Unlock
2026
9.31% 5.92%
Unlock
2027
9.76% 4.83%
Unlock
2028
10.38% 6.35%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ 7.66 8.54
1.86% 11.49%
P/E 19.98
EV/Sales 2.37

9 Analysts have issued a Quest Diagnostics forecast for earnings per share. The average Quest Diagnostics EPS is

$8.54
Unlock
. This is
10.91% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$9.68 25.71%
Unlock
, the lowest is
$8.11 5.32%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $7.66 1.86%
2025
$8.54 11.49%
Unlock
2026
$9.41 10.19%
Unlock
2027
$10.25 8.93%
Unlock
2028
$11.34 10.63%
Unlock

P/E ratio

Current 22.17 24.69%
2025
19.98 9.88%
Unlock
2026
18.13 9.26%
Unlock
2027
16.64 8.22%
Unlock
2028
15.04 9.62%
Unlock

Based on analysts' sales estimates for 2025, the Quest Diagnostics stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.59 22.17%
2025
2.37 8.36%
Unlock
2026
2.28 3.89%
Unlock
2027
2.19 3.83%
Unlock
2028
2.11 3.78%
Unlock

P/S ratio

Current 1.92 20.43%
2025
1.76 8.45%
Unlock
2026
1.69 3.90%
Unlock
2027
1.62 3.82%
Unlock
2028
1.56 3.79%
Unlock

Current Quest Diagnostics Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Redburn Atlantic
Locked
Locked
Locked Apr 02 2025
Baird
Locked
Locked
Locked Mar 20 2025
Citigroup
Locked
Locked
Locked Mar 04 2025
JP Morgan
Locked
Locked
Locked Feb 04 2025
UBS
Locked
Locked
Locked Feb 03 2025
Mizuho
Locked
Locked
Locked Feb 03 2025
Piper Sandler
Locked
Locked
Locked Feb 03 2025
Analyst Rating Date
Locked
Redburn Atlantic:
Locked
Locked
Apr 02 2025
Locked
Baird:
Locked
Locked
Mar 20 2025
Locked
Citigroup:
Locked
Locked
Mar 04 2025
Locked
JP Morgan:
Locked
Locked
Feb 04 2025
Locked
UBS:
Locked
Locked
Feb 03 2025
Locked
Mizuho:
Locked
Locked
Feb 03 2025
Locked
Piper Sandler:
Locked
Locked
Feb 03 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today